von Willebrand factor clearance - biological mechanisms and clinical significance

被引:52
|
作者
O'Sullivan, Jamie M. [1 ]
Ward, Soracha [1 ]
Lavin, Michelle [1 ,2 ]
O'Donnell, James S. [1 ,2 ]
机构
[1] Royal Coll Surgeons Ireland, Irish Ctr Vasc Biol, Haemostasis Res Grp, Dublin, Ireland
[2] St James Hosp, Natl Coagulat Ctr, Dublin, Ireland
基金
爱尔兰科学基金会;
关键词
von Willebrand factor; von Willebrand disease; clearance; macrophage; FACTOR-VIII; ASIALOGLYCOPROTEIN RECEPTOR; DENDRITIC CELLS; IN-VIVO; ADAMTS13; PROTEOLYSIS; MACROPHAGE LECTIN; FACTOR PROPEPTIDE; FACTOR SURVIVAL; VWF PROPEPTIDE; PLASMA-LEVELS;
D O I
10.1111/bjh.15565
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The mechanisms involved in regulating von Willebrand factor (VWF) clearance remain poorly understood. However recent studies have shown that macrophages play a critical role in regulating the half-life of VWF, and have identified specific lectin (including asialoglycoprotein, macrophage galactose-type lectin, Sigec-5 and C-type lectin domain family 4 member M) and scavenger receptors (including low-density lipoprotein receptor-related protein-1, scavenger receptor A1 and stabilin-2) that are involved in VWF clearance. Further studies will be required to determine the relative importance of these individual receptors with respect to physiological and pathological VWF clearance. Nevertheless, recent clinical data have highlighted the importance of enhanced VWF clearance in the pathogenesis of type 1 von Willebrand disease (VWD). Moreover, increased clearance also contributes to reduced VWF levels in many patients with type 2 and type 3 VWD. Improved understanding regarding VWF clearance is not only of direct biological relevance, but may also have important implications for the development of novel therapeutic agents with extended plasma half-lives for the treatment of both VWD and haemophilia A.
引用
收藏
页码:185 / 195
页数:11
相关论文
共 50 条
  • [1] Clearance mechanisms of von Willebrand factor and factor VIII
    Lenting, P. J.
    van Schooten, C. J. M.
    Denis, C. V.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (07) : 1353 - 1360
  • [2] Clearance of von Willebrand factor
    Casari, C.
    Lenting, P. J.
    Wohner, N.
    Christophe, O. D.
    Denis, C. V.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 202 - 211
  • [3] Clearance of von Willebrand factor
    Denis, Cecile V.
    Christophe, Olivier D.
    Oortwijn, Beatrijs D.
    Lenting, Peter J.
    THROMBOSIS AND HAEMOSTASIS, 2008, 99 (02) : 271 - 278
  • [4] Von Willebrand factor's clearance
    Denis, Cecile V.
    Lenting, Peter J.
    HEMATOLOGIE, 2006, 12 (01): : 34 - 43
  • [5] Clinical significance of slightly reduced von Willebrand factor activity
    Bykowska, Ksenia
    Ceglarek, Bernadeta
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2020, 130 (03): : 225 - 231
  • [6] Clinical significance of von Willebrand factor in patients with adult dermatomyositis
    Toshiyuki Komiya
    Nobuo Negoro
    Kyoko Kondo
    Katsuyuki Miura
    Yoshio Hirota
    Junichi Yoshikawa
    Clinical Rheumatology, 2005, 24 : 352 - 357
  • [7] Clinical significance of von Willebrand factor in patients with adult dermatomyositis
    Komiya, T
    Negoro, N
    Kondo, K
    Miura, K
    Hirota, Y
    Yoshikawa, J
    CLINICAL RHEUMATOLOGY, 2005, 24 (04) : 352 - 357
  • [8] The Biological Significance of von Willebrand Factor O-Linked Glycosylation
    Ward, Soracha
    O'Sullivan, Jamie M.
    O'Donnell, James S.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2021, 47 (07): : 855 - 861
  • [9] The von Willebrand factor from basic mechanisms to clinical practice
    Federici, Augusto B.
    BLOOD TRANSFUSION, 2011, 9 : S1 - S2
  • [10] The significance of subendothelial von Willebrand factor
    Rand, JH
    Glanville, RW
    Wu, XX
    Ross, JM
    Zangari, M
    Gordon, RE
    Schwartz, E
    Potter, BJ
    THROMBOSIS AND HAEMOSTASIS, 1997, 78 (01) : 445 - 450